Skillman, NJ · Health Care · Form D filed Sep 21, 2026
iQure Pharma Inc. raised $2.8M
iQure Pharma Inc. is a health care company based in Skillman, New Jersey. In an amended Form D filed with the SEC on September 21, 2026, it reported raising $2,788,315 from 18 investors as part of an offering of up to $4,000,000. The first sale in the offering took place on September 9, 2025.
- 6th Form D since 2023. Earlier new notices: Jun 3, 2026 · Nov 3, 2025 · Jan 16, 2025 · Apr 16, 2024 · Oct 11, 2023. All filings on EDGAR
- Still raising. $1.2M of the $4M offering was still unsold at filing.
$6.6M raised since 2020
5 Form D offerings, as reported to the SEC, the first in Oct 11, 2023. Amendments update a round; they aren't counted twice.
| Filed | Sold | Offering size | Investors |
|---|---|---|---|
| Jun 3, 2026 | $650K | $4M | 1 |
| Nov 3, 2025 | $2.8M | $4M | 18 |
| Jan 16, 2025 | $1.4M | $1.4M | 2 |
| Apr 16, 2024 | $220K | Open | 7 |
| Oct 11, 2023 | $1.5M | $2M | 13 |
Lead score
22 out of 100
filed recently still raising budget to spend
Outreach kit How it works 1:21
A first message that shows you did your homework, written from this filing. Fill in the brackets and send.
Email · subject: Congrats on the new round
Hi [first name], Congrats on the new round. I saw the raise in your SEC filing. Teams at this stage usually start looking at [what you do] right after a round... [Your name]
LinkedIn note
Congrats on the new round. I work with [who you help] on [what you do] right after a raise. Open to connecting?
Call opener
Hi, this is [your name] from [company]. I am calling because you just filed a raise with the SEC...
Find the right person Founders & CEO · Finance · Operations · People & hiring · Sales & marketing
Track this company How it works 0:56
Saved to your dashboard pipeline, with a badge in Explore.
Loading your outreach kit…
The outreach kit is part of Pro. Copy-ready email, LinkedIn and call openers for every new raise, plus daily alerts for the companies you sell to.
Filing details
- Amount raised
- $2,788,315
- Offering size
- $4,000,000
- Investors so far
- 18
- First sale
- September 9, 2025
- Securities offered
- Equity
- Exemption claimed
- Rule 506(b)
- Industry
- Other
- Headquarters
- Skillman, New Jersey
- Incorporated
- Delaware
- Entity type
- Corporation
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D/A (amendment) | $2,788,315 | $4,000,000 | 18 | SEC filing |
Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.
Updated · Raises in the week of Sep 21, 2026 · Health Care funding in New Jersey · September 2026 funding report
Similar raises
Ensho Therapeutics, Inc.
Woodcliff Lake, NJ · filed Oct 155th Form D since 2024Still raising
Surgical Center of South Jersey LP
Mt. Laurel, NJ · filed Oct 811th Form D since 2010Still raising
Xenon Ophthalmics Inc
Jersey City, NJ · filed Oct 62nd Form D since 2023
Lisata Therapeutics, Inc.
Basking Ridge, NJ · filed Oct 2
Clinical-stage biopharmaceutical company developing therapies for solid tumors, including cancer drugs designed to improve delivery into tumor tissue.
8th Form D since 2014
Morris County Surgical Center, LLC
Parsippany, NJ · filed Sep 283rd Form D since 2021Still raising
Acuitive Technologies, Inc.
Allendale, NJ · filed Sep 244th Form D since 2021Still raising
OLI Technologies, Inc.
North Brunswick, NJ · filed Sep 42nd Form D since 2025
Grace Therapeutics, Inc.
Princeton, NJ · filed Aug 115th Form D since 2011